CRMD - CorMedix GAAP EPS of -$0.20 misses by $0.01 revenue of $0.03M beats by $0.03M
2023-03-30 07:32:20 ET
- CorMedix press release ( NASDAQ: CRMD ): Q4 GAAP EPS of -$0.20 misses by $0.01 .
- Revenue of $0.03M (-50.0% Y/Y) beats by $0.03M .
- Cash and short-term investments, excluding restricted cash, at December 31, 2022 amounted to $58.8M.
For further details see:
CorMedix GAAP EPS of -$0.20 misses by $0.01, revenue of $0.03M beats by $0.03M